Question 1

What were the reasons for my early withdrawal from the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler clinical trial (NCT02172560). Contact the study team or your healthcare provider for specific answers.

Question 2

How does my experience compare to others who withdrew early?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler clinical trial (NCT02172560). Contact the study team or your healthcare provider for specific answers.

Question 3

What medications should I consider now that I am no longer in the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler clinical trial (NCT02172560). Contact the study team or your healthcare provider for specific answers.

Question 4

Can you explain the findings from this trial and how they relate to my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Collection of Vital Status and Pulmonary Medication Usage Data for Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered by the Respimat Inhaler clinical trial (NCT02172560). Contact the study team or your healthcare provider for specific answers.

What this study is about